​

Rallybio (RLYB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Rallybio Revenue Highlights

Latest Revenue (Y)

$858.00K

Latest Revenue (Q)

$212.00K

Main Segment (Y)

Collaboration And License Revenue

Rallybio Revenue by Period

Rallybio Revenue by Year

DateRevenueChange
2025-12-31$858.00K34.91%
2024-12-31$636.00K100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Rallybio generated $858.00K in revenue during NA 2025, up 34.91% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Rallybio Revenue by Quarter

DateRevenueChange
2025-09-30$212.00K-
2025-06-30$212.00K-
2025-03-31$212.00K457.89%
2024-12-31$38.00K-87.29%
2024-09-30$299.00K-
2024-06-30$299.00K100.00%
2024-03-31--100.00%
2023-12-31$228.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Rallybio generated $212.00K in revenue during Q3 2025, up 0.00% compared to the previous quarter, and up 70.90% compared to the same period a year ago.

Rallybio Revenue Breakdown

Rallybio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Collaboration And License Revenue$858.00K$636.00K
License$800.00K-

Rallybio's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration And License Revenue (51.75%), and License (48.25%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24
Collaboration And License Revenue$222.00K$212.00K$212.00K$212.00K$337.00K$299.00K

Rallybio's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Collaboration And License Revenue (100.00%).

Rallybio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SONNSonnet BioTherapeutics$1.00M-
RLYBRallybio$858.00K$212.00K
IBIOiBio$400.00K-
XCURExicure--
KLTOKlotho Neurosciences--
ITRMIterum Therapeutics-$390.00K
BOLDBoundless Bio--
INTSIntensity Therapeutics--
QTTBQ32 Bio--
CVKDCadrenal Therapeutics--
TAOXTAO Synergies--

RLYB Revenue FAQ

What is Rallybio’s yearly revenue?

Rallybio's yearly revenue for 2025 was $858K, representing an increase of 34.91% compared to 2024. The company's yearly revenue for 2024 was $636K, representing an increase of 100.00% compared to 2023. RLYB's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Rallybio’s quarterly revenue?

Rallybio's quarterly revenue for Q3 2025 was $212K, a 0% increase from the previous quarter (Q2 2025), and a -29.10% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $212K, a 0% increase from the previous quarter (Q1 2025), and a -29.10% decrease year-over-year (Q2 2024). RLYB's quarterly revenue for Q1 2025 was $212K, a 457.89% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Rallybio’s revenue growth rate?

Rallybio's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Rallybio’s revenue streams?

Rallybio's revenue streams in c 25 are Collaboration And License Revenue, and License. Collaboration And License Revenue generated $858K in revenue, accounting 51.75% of the company's total revenue, up 34.91% year-over-year. License generated $800K in revenue, accounting 48.25% of the company's total revenue

What is Rallybio’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Rallybio was Collaboration And License Revenue. This segment made a revenue of $858K, representing 51.75% of the company's total revenue.